NEWS
October 22, 1992 | IRENE WIELAWSKI, TIMES STAFF WRITER
In the turbulent aftermath of the world's first pig-to-human liver transplant, the surgeon, Dr. Leonard Makowka, is embroiled in a dispute with a San Diego biotechnology company that claims him as a vice president, along with exclusive rights to market any innovations emerging from Makowka's pig liver research at Cedars-Sinai Medical Center. Xenogenex Inc.